Trisequens

Medicinal product

(Invented) name

Trisequens

Active substance (s)

Estradiolis+Estradiolis/Noretisterono acetatas+Estradiolis

Strength

2 mg + 2 mg/1 mg + 1 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03FB05, Norethisterone and estrogen

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-12-10

Date of renewal

Documents

3062_Trisequens plėvele dengtos tabletės_PZ_2025-12-10.docx

3062_Trisequens plėvele dengtos tabletės_PL_2025-12-10.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Mėlynoje tabletėje yra	1 vnt.
Estradiolis	2 mg
Baltoje tabletėje yra	1 vnt.
Estradiolis	2 mg
Noretisterono acetatas	1 mg
Raudonoje tabletėje yra	1 vnt.
Estradiolis	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119429	105534	1105534	tablečių talpyklė	N28		Receptinis	LT/L/25/3062/001	Netiekiama	-	2026-04-01	No	-	-	Download
119430	105535	1105535	tablečių talpyklė	N3 x 28		Receptinis	LT/L/25/3062/002	Netiekiama	-	2026-04-01	No	-	-

Stadijos

Data	Stadija
2025-12-10	Registruotas